The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma.
Schober SJ, Schoening C, Eck J, Middendorf C, Lutsch J, Knoch P, von Ofen AJ, Gassmann H, Thiede M, Hauer J, Kolk A, Mantwill K, Gschwend JE, Burdach SEG, Nawroth R, Thiel U, Holm PS.
Schober SJ, et al. Among authors: eck j.
Clin Cancer Res. 2023 May 15;29(10):1996-2011. doi: 10.1158/1078-0432.CCR-22-1961.
Clin Cancer Res. 2023.
PMID: 36892582